Publications
41
Citations
754
Est. group size
—
Recurring co-author estimate
Active years
19
Publishing since 2008
Lindsay Blazin conducts medical research in pediatric hematology and oncology (blood and cancer care for children and young people). The work spans two main directions: clinical studies of childhood lymphomas, especially nodular lymphocyte-predominant Hodgkin lymphoma, and studies of communication, equity, and quality-of-life issues facing young cancer patients and their families. Topics include how clinicians talk with patients, barriers for families who speak languages other than English, and the emotional experiences of patients and grieving parents.
Publication activity has been steady over the past decade, averaging around 3-4 papers per year in recent years with some year-to-year variation.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses
Blood Advances · 2026
- Advice From Adolescents With Cancer, Their Caregivers, and Clinicians on Utilizing and Improving Patient Portals in Adolescent Oncology Care
Pediatric Blood & Cancer · 2026
- 23 | RADIOTHERAPY IMPROVES PROGRESSION‐FREE SURVIVAL FOR STAGE IA NLPHL: A RETROSPECTIVE REPORT FROM THE GLOBAL NLPHL ONE WORKING GROUP (GLOW)
Hematological Oncology · 2025
- Benefits, Problems, and Motivations for Using the Online Patient Portal in Adolescent Oncology: Interviews With Adolescents and Parents
JCO Clinical Cancer Informatics · 2025
- Barriers to Equitable Pediatric Oncologic Care in the United States
Pediatric Annals · 2025
- International Prognostic Score for Nodular Lymphocyte–Predominant Hodgkin Lymphoma
Journal of Clinical Oncology · 2024
- Clinical trial recruitment of people who speak languages other than English: a Children’s Oncology Group report
JNCI Cancer Spectrum · 2024
- “Understanding why she had to leave me”: The roles of religion and spirituality in narratives of parents grieving the loss of a child to cancer
Death Studies · 2024
- Multilevel challenges to equitable inclusion of children in trials when parents use languages other than English: A qualitative report from Children's Oncology Group's Diversity and Health Disparities Committee Language Equity Working Group
Pediatric Blood & Cancer · 2024
- Clinical trial recruitment of people who speak languages other than English: a Children’s Oncology Group report
UNC Libraries · 2024
- THE PROGNOSTIC IMPACT OF CLINICAL FACTORS AND IMMUNOARCHITECTURAL PATTERNS FOR NODULAR LYMPHOCYTE‐PREDOMINANT HODGKIN LYMPHOMA: AN INTERNATIONAL STUDY BY GLOW
Hematological Oncology · 2023
- International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
SSRN Electronic Journal · 2023
- Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2022
- Approaches for Discussing Clinical Trials with Pediatric Oncology Patients and Their Families
Current Oncology Reports · 2022
- Advice to Clinicians on Communication from Adolescents and Young Adults with Cancer and Parents of Children with Cancer
Children · 2022
- Pediatric Blood & Cancer×6
- Journal of Pain and Symptom Management×6
- PEDIATRICS×4
- Children×2
- JCO Oncology Practice×2
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile